Bojarska-Junak Agnieszka, Hus Iwona, Chocholska Sylwia, Wasik-Szczepanek Ewa, Sieklucka Małgorzata, Dmoszyńska Anna, Roliński Jacek
Department of Clinical Immunology, Medical University of Lublin, Jaczewskiego 8, 20-954 Lublin, Poland.
Leuk Res. 2009 Oct;33(10):1319-27. doi: 10.1016/j.leukres.2009.03.030. Epub 2009 Apr 23.
B-cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL) are involved in normal B cell survival and differentiation. We analyzed BAFF and APRIL plasma levels in patients with B-cell chronic lymphocytic leukemia (B-CLL). We also tested intracellular BAFF and APRIL expression in B-CLL and evaluated their prognostic relevance. The percentage of leukemic B cells with intracellular APRIL or BAFF expression correlated significantly with adverse prognostic factors such as ZAP-70 and CD38. Moreover, we found a close relationship between LPL protein expression or LPL/ADAM29 MFI ratio and proportion of B-CLL cells with intracellular BAFF or APRIL expression. Furthermore, patients with a low percentage of leukemic cells with intracellular BAFF or APRIL expression had a significantly longer overall survival than those with a high proportion of APRIL or BAFF positive leukemic cells.
B细胞活化因子(BAFF)和增殖诱导配体(APRIL)参与正常B细胞的存活和分化。我们分析了B细胞慢性淋巴细胞白血病(B-CLL)患者的BAFF和APRIL血浆水平。我们还检测了B-CLL中细胞内BAFF和APRIL的表达,并评估了它们的预后相关性。白血病B细胞中细胞内APRIL或BAFF表达的百分比与ZAP-70和CD38等不良预后因素显著相关。此外,我们发现脂蛋白脂肪酶(LPL)蛋白表达或LPL/ADAM29平均荧光强度(MFI)比值与细胞内BAFF或APRIL表达的B-CLL细胞比例之间存在密切关系。此外,细胞内BAFF或APRIL表达的白血病细胞百分比低的患者总生存期明显长于APRIL或BAFF阳性白血病细胞比例高的患者。